UN
Unicycive Therapeutics, Inc.
UNCY · NASDAQ
$5.16 -1.53% (-$0.08)
1M +1.78%
Market Cap $141.5M
P/E Ratio -
Div. Yield -
ROE 88.81%
Bulios Fair Price
$3.9
24.4% downside
Trenutna cena
$5.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica UNCY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
72 /100
Cheap P/B 2.66x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 48.90%
ROIC 61.44%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -837.67x
Debt/Equity 0.01x
Current ratio 3.81x
Stability
5 /100
Unstable Profitable years 0
Beta 1.78x
EPS volatility 216.62%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o UNCY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shalabh K. Gupta
Employees
21
Headquarters
Mountain View
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report